Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 2Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Sarcoma 1Other hematologic neoplasm 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Breast Neoplasms 2Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1

Interventions

Exercise 126Surveys and Questionnaires 60Standard of Care 59Early Intervention, Educational 55Methods 54Educational Status 53Magnetic Resonance Spectroscopy 50Acupuncture Therapy 48Blood Specimen Collection 46Radiotherapy 39Mammography 39Control Groups 35Counseling 32Therapeutics 30Practice Guidelines as Topic 30Cyclophosphamide 29Biopsy 28Sentinel Lymph Node Biopsy 27Psychiatric Rehabilitation 27Neoadjuvant Therapy 24Yoga 23Mastectomy, Segmental 23Resistance Training 22Interviews as Topic 21Surgical Procedures, Operative 19Palliative Care 19High-Energy Shock Waves 19Trastuzumab 18Doxorubicin 18Cognitive Behavioral Therapy 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Darbepoetin alfa × Breast × Clear all
NCT06184867 2026-03-06

CATALYST

Rutgers, The State University of New Jersey

Phase NA Completed
50 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT00309920 2009-02-09

Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer

National Cancer Institute (NCI)

Phase NA Unknown
1,234 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡